Does RISANKIZUMAB-RZAA Cause Deafness? 165 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Deafness have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
165
Reports of Deafness with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
0
Deaths
16
Hospitalizations
How Dangerous Is Deafness From RISANKIZUMAB-RZAA?
Of the 165 reports, 16 (9.7%) required hospitalization.
Is Deafness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 165 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Deafness?
ADALIMUMAB (1,300)
METHOTREXATE (635)
ETANERCEPT (629)
SACUBITRIL\VALSARTAN (471)
APIXABAN (455)
LENALIDOMIDE (397)
TOFACITINIB (388)
CISPLATIN (344)
AMIKACIN (320)
ATORVASTATIN (308)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Deafness Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA